Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126482372 | 12648237 | 2 | F | 20160915 | 20160812 | 20160923 | EXP | PHHY2016BR108914 | SANDOZ | 0.00 | M | Y | 0.00000 | 20160923 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126482372 | 12648237 | 1 | PS | ENALAPRIL SANDOZ | ENALAPRIL | 1 | Unknown | FN1482 | 75048 | FILM-COATED TABLET | |||||||||
| 126482372 | 12648237 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | U | 0 | ||||||||||
| 126482372 | 12648237 | 3 | C | ENAPROTEC | 2 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126482372 | 12648237 | 1 | Product used for unknown indication |
| 126482372 | 12648237 | 2 | Product used for unknown indication |
| 126482372 | 12648237 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126482372 | 12648237 | HO |
| 126482372 | 12648237 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126482372 | 12648237 | Blood pressure increased | |
| 126482372 | 12648237 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |